Constructive Biology
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- $74M
Investors
- 8
About Constructive Biology
Constructive Biology Limited, founded in 2021, is headquartered in Cambridge, UK. The company focuses on developing advanced biotechnology solutions. Jason Chin is the founder, and Ola Wlodek serves as the CEO.10 mn from Innovate UK on March 27, 2025.Constructive Biology Limited specializes in innovative biotechnology solutions, focusing on the synthesis of programmable biomolecules and whole genome writing. Their core offerings include the patented Syn61 strain, which allows for the expansion of the genetic code and the creation of highly specific biomolecules. This technology addresses challenges in drug discovery and biomanufacturing, enabling advancements in next-generation therapeutics, such as antibody drug conjugates, and industrial applications, including the development of phage-resistant strains. The company primarily serves the pharmaceutical and biotechnology sectors, targeting clients such as research institutions and companies engaged in drug development and biomanufacturing processes.Constructive Biology Limited generates revenue through strategic partnerships and direct business arrangements with clients in the biotechnology and pharmaceutical sectors. The company engages in B2B transactions, where clients utilize its Syn61 strain and other proprietary technologies for their biomanufacturing needs. Revenue is derived from licensing agreements, collaborations for R&D initiatives, and supply contracts related to the provision of customizable biomolecules. The structure of these transactions includes upfront fees, milestone payments tied to development progress, and ongoing royalties based on product sales. The company is also exploring opportunities to expand into new markets, targeting specific regions known for their biopharmaceutical industries by 2026. Upcoming product launches include new programmable biomolecules designed to further assist clients in drug discovery and biomanufacturing processes.
Who invested in Constructive Biology
8 investors across 3 rounds
See all investors in Constructive Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Constructive Biology
Who invested in Constructive Biology?
Constructive Biology has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Constructive Biology raised?
Constructive Biology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Constructive Biology last raise money?
Constructive Biology's most recent round on record is a Series A, in Mar 2025.
What does Constructive Biology do?
Constructive Biology Limited, founded in 2021, is headquartered in Cambridge, UK.
Where is Constructive Biology headquartered?
Constructive Biology is headquartered in Cambridge, UK.
Which VCs invest in companies like Constructive Biology?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Constructive Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Constructive Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.